RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1

BACKGROUND: 40–50% of colorectal cancer (CRC) patients develop metastatic disease; the presence of metastasis hinders the effective treatment of cancer through surgery, chemotherapy and radiotherapy, which makes 5-year survival rate extremely low; therefore, studying CRC metastasis is crucial for di...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Exp Clin Cancer Res
Main Authors: Zhang, Mengmeng, Miao, Fei, Huang, Rong, Liu, Wenjie, Zhao, Yuechao, Jiao, Tao, Lu, Yalan, Wu, Fan, Wang, Xiaojuan, Wang, Han, Zhao, Hong, Ju, Hongge, Miao, Shiying, Wang, Linfang, Song, Wei
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5807852/
https://ncbi.nlm.nih.gov/pubmed/29426364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0687-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki